Stifel Financial’s AbbVie ABBV Stock Holding History

Stifel Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$812M	Buy	3,732,204 +1,264,508	+51%	+$280M	0.75%	19
2025 Q4	$564M	Sell	2,467,696 -5,456	-0.2%	-$1.24M	0.51%	32
2025 Q3	$573M	Sell	2,473,152 -27,294	-1%	-$5.56M	0.52%	34
2025 Q2	$464M	Buy	2,500,446 +102,160	+4%	+$19M	0.45%	45
2025 Q1	$502M	Sell	2,398,286 -180,944	-7%	-$35.2M	0.53%	38
2024 Q4	$458M	Buy	2,579,230 +77,564	+3%	+$14.3M	0.48%	42
2024 Q3	$494M	Sell	2,501,666 -28,036	-1%	-$5.23M	0.52%	34
2024 Q2	$434M	Buy	2,529,702 +73,733	+3%	+$12.2M	0.49%	45
2024 Q1	$447M	Buy	2,455,969 +143,017	+6%	+$24.6M	0.51%	44
2023 Q4	$358M	Sell	2,312,952 -36,468	-2%	-$5.32M	0.45%	52
2023 Q3	$350M	Sell	2,349,420 -7,677	-0.3%	-$1.13M	0.49%	50
2023 Q2	$318M	Sell	2,357,097 -232,261	-9%	-$34.1M	0.43%	56
2023 Q1	$413M	Sell	2,589,358 -248,671	-9%	-$38M	0.59%	33
2022 Q4	$459M	Buy	2,838,029 +22,100	+0.8%	+$3.39M	0.69%	24
2022 Q3	$378M	Buy	2,815,929 +83,447	+3%	+$12M	0.62%	33
2022 Q2	$419M	Sell	2,732,482 -57,361	-2%	-$8.77M	0.66%	25
2022 Q1	$452M	Sell	2,789,843 -4,965	-0.2%	-$721K	0.62%	29
2021 Q4	$378M	Buy	2,794,808 +92,082	+3%	+$10.9M	0.5%	41
2021 Q3	$292M	Buy	2,702,726 +87,752	+3%	+$10M	0.43%	55
2021 Q2	$295M	Buy	2,614,974 +71,832	+3%	+$8.09M	0.44%	54
2021 Q1	$275M	Buy	2,543,142 +301,638	+13%	+$32.3M	0.45%	55
2020 Q4	$240M	Buy	2,241,504 +10,851	+0.5%	+$1.04M	0.43%	57
2020 Q3	$195M	Buy	2,230,653 +40,299	+2%	+$3.79M	0.4%	65
2020 Q2	$215M	Buy	2,190,354 +133,135	+6%	+$11.7M	0.49%	50
2020 Q1	$157M	Sell	2,057,219 -221,990	-10%	-$18.9M	0.43%	62
2019 Q4	$202M	Buy	2,279,209 +130,911	+6%	+$10.9M	0.42%	57
2019 Q3	$163M	Sell	2,148,298 -238,125	-10%	-$16.3M	0.41%	53
2019 Q2	$174M	Buy	2,386,423 +137,955	+6%	+$10.8M	0.45%	47
2019 Q1	$181M	Buy	2,248,468 +71,527	+3%	+$5.85M	0.51%	33
2018 Q4	$201M	Buy	2,176,941 +54,132	+3%	+$4.76M	0.65%	25
2018 Q3	$201M	Buy	2,122,809 +88,901	+4%	+$8.43M	0.58%	27
2018 Q2	$189M	Buy	2,033,908 +45,891	+2%	+$4.48M	0.58%	30
2018 Q1	$188M	Sell	1,988,017 -154,733	-7%	-$17M	0.59%	28
2017 Q4	$207M	Sell	2,142,750 -183,192	-8%	-$17.3M	0.66%	25
2017 Q3	$207M	Sell	2,325,942 -565,927	-20%	-$43.1M	0.72%	17
2017 Q2	$210M	Sell	2,891,869 -9,035	-0.3%	-$607K	0.78%	16
2017 Q1	$189M	Sell	2,900,904 -31,502	-1%	-$1.98M	0.73%	18
2016 Q4	$184M	Buy	2,932,406 +51,924	+2%	+$3.17M	0.78%	18
2016 Q3	$182M	Buy	2,880,482 +30,938	+1%	+$2M	0.82%	16
2016 Q2	$176M	Buy	2,849,544 +183,495	+7%	+$11.2M	0.82%	17
2016 Q1	$152M	Buy	2,666,049 +131,675	+5%	+$7.34M	0.81%	16
2015 Q4	$150M	Buy	2,534,374 +615,467	+32%	+$35.4M	0.78%	14
2015 Q3	$104M	Buy	1,918,907 +32,510	+2%	+$2.12M	0.59%	29
2015 Q2	$127M	Buy	1,886,397 +165,482	+10%	+$10.8M	0.66%	22
2015 Q1	$101M	Buy	1,720,915 +733,325	+74%	+$44.3M	0.55%	27
2014 Q4	$64.6M	Buy	987,590 +230,821	+31%	+$14.6M	0.36%	51
2014 Q3	$43.7M	Buy	756,769 +323,085	+74%	+$17.9M	0.38%	42
2014 Q2	$24.5M	Buy	433,684 +4,471	+1%	+$235K	0.22%	109
2014 Q1	$22.1M	Buy	+429,213	New	+$21.7M	0.21%	111

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stifel Financial's ABBV Position: Q1 2026 in Review

Stifel Financial increased its AbbVie (ABBV) stake by 51% in Q1 2026, buying an estimated $280M and bringing the position to 3,732,204 shares worth $812M. The position accounts for 0.75% of the portfolio, ranked #19.

Stifel Financial first reported a position in ABBV in Q1 2014 and has held it in 49 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Stifel Financial held 3,732,204 shares of AbbVie worth $812M as of Q1 2026.
Stifel Financial bought 1,264,508 AbbVie shares in Q1 2026, an estimated $280M.
AbbVie made up 0.75% of Stifel Financial's portfolio in Q1 2026, its #19 holding.
Stifel Financial first reported a position in AbbVie in Q1 2014 and has held it in 49 quarters since.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.